CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Amino Acid Injection
FDA source answer
FDA currently lists this ingredient in shortage.
FDA source statuses: Current. First FDA posting: 2020-12-08. Latest FDA row update: 2026-10-02.
FDA lists 16 package records, with companies: B. Braun Medical Inc., Baxter Healthcare, Baxter Healthcare Company, Baxter Healthcare Corporation, ICU Medical Inc., Otsuka ICU Medical LLC. Package NDCs: 0264-1933-10, 0264-4500-00, 0264-4500-05, 0338-0499-06, 0338-0502-03, 0338-0502-06, 0338-0644-03, 0338-0644-04, 0338-0644-06, 0338-1130-03, 0338-1130-04, 0338-1130-06, 0990-4178-03, 0990-4179-05, 0990-7171-17, 0990-7172-17.
FDA shortage reason: Shortage of an active ingredient; Shortage of an inactive ingredient component
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| B. Braun Medical Inc. | 0264-4500-00 | Plenamine, Injection, 0.15 (NDC 0264-4500-00) | Available | 2026-09-22 |
| B. Braun Medical Inc. | 0264-4500-05 | Plenamine, Injection, 0.15 (NDC 0264-4500-05) | Available | 2026-09-22 |
| B. Braun Medical Inc. | 0264-1933-10 | TrophAmine 10%, Injection, 0.1 (NDC 0264-1933-10) | Available | 2026-09-22 |
| Baxter Healthcare | 0338-0502-03 | Clinisol 15% Sulfite Free In Plastic Container, Injection, 0.15 (NDC 0338-0502-03) | Available | 2026-10-02 |
| Baxter Healthcare | 0338-0502-06 | Clinisol 15% Sulfite Free In Plastic Container, Injection, 0.15 (NDC 0338-0502-06) | Available | 2026-10-02 |
| Baxter Healthcare | 0338-0499-06 | PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER, Injection, 2.76 g/100 mL; 1.96 g/100 mL; 600 mg/100 mL; 1.02 g/100 mL; 2.06 g/100 mL; 1.18 g/100 mL; 1.08 g/100 mL; 1.08 g/100 mL; 1.35 g/100 mL; 760 mg/100 mL; 1 g/100 mL; 1.34 g/100 mL; 1.02 g/100 mL; 980 mg/100 mL; 320 mg/100 mL; 50 mg/100 mL; 1.44 g/100 mL (NDC 0338-0499-06) | Available | 2026-10-02 |
| Baxter Healthcare | 0338-1130-03 | Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-03) | Available | 2026-10-02 |
| Baxter Healthcare | 0338-1130-04 | Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-04) | Available | 2026-10-02 |
| Baxter Healthcare | 0338-1130-06 | Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-06) | Available | 2026-10-02 |
| Baxter Healthcare | 0338-0644-03 | Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100 mL (NDC 0338-0644-03) | Unavailable | 2026-10-02 |
| Baxter Healthcare | 0338-0644-04 | Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100 mL (NDC 0338-0644-04) | Available | 2026-10-02 |
| Baxter Healthcare | 0338-0644-06 | Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100 mL (NDC 0338-0644-06) | Available | 2026-10-02 |
| Otsuka ICU Medical LLC | 0990-7172-17 | Aminosyn II 10% In Plastic Container, Injection, 0.1 (NDC 0990-7172-17) | Available | 2026-10-01 |
| Otsuka ICU Medical LLC | 0990-7171-17 | Aminosyn II 15% In Plastic Container, Injection, 0.15 (NDC 0990-7171-17) | Available | 2026-10-01 |
| Otsuka ICU Medical LLC | 0990-4179-05 | Aminosyn-PF 10%, Injection, 0.1 (NDC 0990-4179-05) | Unavailable | 2026-10-01 |
| Otsuka ICU Medical LLC | 0990-4178-03 | Aminosyn-PF 7%, Injection, 0.07 (NDC 0990-4178-03) | Unavailable | 2026-10-01 |
Source facts
Grouped generic ingredient: Amino Acid Injection · 16 package records
Therapeutic categories: Gastroenterology
Dosage forms: Injection
Routes: INTRAVENOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.